Survey of False-positive Reactivity of Latex Agglutination Test for Kala-azar (Katex) without Urine Sample Boiling Process in Autoimmune Patients
,
Abstract
Background: Latex agglutination test for Kala-azar (KAtex) is an easy, inexpensive, and field-applicable antigen detection test. However, the main drawback of this method is the boiling step applied to remove false positivity of the test. This study was conducted to survey false positivity results of latex agglutination test for KAtex without boiling process in urine of some autoimmune patients.
Methods: Ninety-two urine samples from autoimmune patients including systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), scleroderma, autoimmune vasculitis, vitiligo, pemphigus and Wagner cases and 20 urine samples from healthy individuals were collected from Kerman Province in Southeastern Iran in 2010-2011. All urine samples were checked by KAtex after boiling for 5 min false positivity rate of the test was surveyed in different healthy and patients groups while boiling process was removed. Rheumatoid factor (RF) then was checked in sera of all cases to evaluate the relationship between RF and KAtex false positivity.
Results: All samples represented negative results with KAtex when boiling was performed (100% specificity). Then, 20% positivity was evident in healthy cases. False-positive reactivity was more prominent observed in patient groups than healthy individuals, except in vitiligo. However, a significant difference was only observed in RA group (P<0.05). RF was related to KAtex false positivity.
Conclusion: RA was described as the autoimmune disease in which KAtex false positivity was higher than normal population. RF or its metabolic products may have role in false positivity of KAtex but this finding needs to be confirmed by more reliable and improved experiments. Overall, immune system products should be considered in attempts for modification of KAtex for boiling process removal.
Sundar S, Chakravarty J (2012). Recent advances in the diagnosis and treatment of kala-azar. Natl Med J India, 25: 85–89.
Alvar J, Vélez ID, Bern C et al (2012). Leishmaniasis worldwide and global estimates of its incidence. PLoS One, 7:e35671.
Mohebali M, Edrissian GH , Shirzadi MR et al (2011). An observational study on the current distribution of visceral leishmaniasis in different geographical zones of Iran and implication to health policy. Travel Med Infect Dis, 9: 67-74.
Sarkari B, Hatam G, Ghatee M (2012). Epidemio-logical features of visceral leishmaniasis in Fars Province, Southern Iran. Iran J Public Health, 41: 94-9.
Mohebali M (2013). Visceral leishmaniasis in Iran: Review of the epidemiological and cinical features. Iran J Parasitol, 8: 348-358.
Ghatee MA, Sharifi I, Haghdoost AA et al (2013). Spatial correlations of population and ecological factors with distribution of visceral leishmaniasis cases in southwestern Iran. J Vector Borne Dis, 50: 179–87.
Hosseininasab A, Sharifi I, Daei MH, Zarean M, Dadkhah M (2014). Causes of pediatric visceral leishmaniasis in Southeastern Iran. Iran J Parasitol, 9: 584-87.
Sarkari B, Naraki T, Ghatee MA, AbdolahiK-habisi S, Davami MH (2016). Visceral leishmaniasis in southwestern Iran: A re-trospective clinico-hematological analysis of 380 consecutive hospitalized cases (1999–2014). PLoS One, 11(3): e0150406.
Ghatee M, Sharifi I, Mirhendi H, Kanannejad Z, Hatam G (2013). Investigation of double-band electrophoretic pattern of ITS-rDNA region in Iranian isolates of Leishmania tropica. Iran J Parasitol, 8: 264–72.
Hajjaran H, Mohebali M, Mamishi S et al (2013). Molecular identification and polymorphism de-termination of cutaneous and visceral leishma-niasis agents isolated from human and animal hosts in Iran. Biomed Res Int Article ID 789326.
Ghatee MA, Sharifi I, Kuhls K et al (2014). Hete-rogeneity of the internal transcribed spacer region in Leishmania tropica isolates from southern Iran. Exp Parasitol, 144: 44–51.
Izadi S, Mirhendi S, Jalalizand N, Khodadadi H, Mohebali M, Nekoeian S, Jamshidi A, Ghatee MA (2016). Molecular epidemiological survey of cutaneous leishmaniasis in two highly endemic metropolises of Iran, application of FTA cards for DNA extraction from Giemsa-stained slides. Jundishapur J Microbiol, 9(2): e32885.
Karamian M, Kuhls K, Hemmati M, Ghatee MA (2016). Phylogenetic structure of Leishmania tropica in the new endemic focus Birjand in East Iran in comparison to other Iranian endemic regions. Acta Trop, 158: 68–76.
Mohebali M (2012). Epidemiological Status of Vis-ceral leishmaniasis in Iran: Experiences and review of literature. J Clinic Experiment Pathol, S3:003.
Mansueto P, Seidita A, Vitale G, Cascio A (2014). Leishmaniasis in travelers: A literature review. Travel Med Infect Dis, 12: 563–81.
Sundar S, Rai M (2002). Laboratory diagnosis of visceral leishmaniasis. Clin Diagn Lab Immunol, 9: 951–58.
Pace D (2015). Leishmaniasis. J Infect, 69: S10–8. doi:10.1016/j.jinf.2014.07.016.
Singh S (2006). New developments in diagnosis of leishmaniasis. Indian J Med Res, 123: 311-30.
Badaró R, Reed SG, Carvalho EM (1983). Immunofluorescent antibody test in American visceral leishmaniasis: sensitivity and specificity of different morphological forms of two Leishmania species. Am J Trop Med Hyg, 32: 480–84.
Harith AE, Kolk AHJ, Kager PA et al (1986). A simple and economical direct agglutination test for serodiagnosis and seroepidemiological studies of visceral leishmaniasis. Trans R Soc Trop Med Hyg, 80: 583–86.
Akhoundi B, Mohebali M, Babakhan L et al (2010). Rapid detection of human Leishmania infantum infection: a comparative field study using the fast agglutination screening test and the direct agglutination test. Travel Med Infect Dis, 8: 305–10.
Attar ZJ, Chance ML, el-Safi S et al (2001). Latex agglutination test for the detection of urinary antigens in visceral leishmaniasis. Acta Trop, 78: 11–16.
Habib ZH, Lutfor AB, Jhora ST, Ahmed I, Akhter H (2014). Validity of KAtex test for the diagnosis of visceral leishmaniasis in endemic region of Bangladesh. Bangladesh J Infect Dis, 1: 8-11.
El-Safi SH, Abdel Haleem A, Hammad A et al (2003). Field evaluation of latex agglutination test for detecting urinary antigens in visceral leishmaniasis in Sudan 2003. East Mediterr Health J, 9: 844-55.
Diro E, Techane Y, Tefera T et al (2007). Field evaluation of FD-DAT, rK39 dipstick and KATEX (urine latex agglutination) for diagnosis of visceral leishmaniasis in northwest Ethiopia. Trans R Soc Trop Med Hyg, 101: 908–14.
Boelaert M, El-Safi S, Hailu A et al (2008). Diagnostic tests for kala-azar: a multi-centre study of the freeze-dried DAT, rK39 strip test and KAtex in East Africa and the Indian subcontinent. Trans R Soc Trop Med Hyg, 102: 32–40.
Salam MA, Khan MGM, Mondal D (2011). Urine antigen detection by latex agglutination test for diagnosis and assessment of initial cure of visceral leishmaniasis. Trans R Soc Trop Med Hyg,105: 269–72.
Rijal S, Boelaert M, Regmi S et al (2004). Evaluation of a urinary antigen based latex agglutination test in the diagnosis of kala‐azar in eastern Nepal. Trop Med Int Health, 9: 724–29.
Molai S, Mohebali M, Akhoundi B, Zarei Z (2006). Evaluation of latex agglutination test (KATEX®) for the detection of urinary antigens in human visceral leishmaniasis. J Sch Public Heal Inst Public Heal Res, 4: 1–8.
Ghatei MA, Hatam GR, Hossini MH, Sarkari B (2009). Performance of latex agglutination test (KAtex) in diagnosis of visceral leishmaniasis in Iran. Iran J Immunol, 6: 202–7.
Sarkari B, Chance M, Hommel M (2002). Antigenuria in visceral leishmaniasis: detection and partial characterisation of a carbohydrate antigen. Acta Trop, 82: 339–48.
Hatam GR, Ghatee MA, Hossini SMH, Sarkari B (2009). Improvement of the newly developed latex agglutination test (Katex) for diagnosis of visceral leishmaniasis. J Clin Lab Anal, 23: 202–5.
Vallur AC, Tutterrow YL, Mohamath R et al (2015). Development and comparative evaluation of two antigen detection tests for visceral leishmaniasis. BMC Infect Dis,15: 384.
Palosuo T, Tilvis R, Strandberg T, Aho K (2003). Filaggrin related antibodies among the aged. Ann Rheum Dis, 62: 261–63.
Harboe M (1988). Rheumatoid factors in leprosy and parasitic diseases. Scand J Rheumatol Suppl, 75: 309–13.
Atta AM, Carvalho EM, Jerônimo SMB, Sousa Atta MLB (2007). Serum markers of rheumatoid arthritis in visceral leishmaniasis: Rheumatoid factor and anti-cyclic citrullinated peptide antibody. J Autoimmun, 28: 55–58.
Sultan BA, Akhtar K, Al-Asady RA-A, Al-Faham MA, Ara A, Sherwani RK (2014). Autoantibodies in visceral leishmaniasis-a comprehensive study. Int J Curr Microbiol App Sci, 3: 635–40.
Nozzi M, Del Torto M, Chiarelli F, Breda L (2014). Leishmaniasis and autoimmune diseases in pediatric age. Cell Immunol, 292: 9–13.
Santana IU, Dias B, Nunes EAS, Rocha FAC Da, Silva FS, Santiago MB (2015). Visceral leishmaniasis mimicking systemic lupus erythematosus: Case series and a systematic literaturereview.Semin Arthritis Rheum, 44: 658–65.
Lee J-H, Jang JW, Cho CH et al (2014). False-positive results for rapid diagnostic tests for malaria in patients with rheumatoid factor. J Clin Microbiol, 52: 3784–87.
Grobusch MP, Alpermann U, Schwenke S, Jelinek T, Warhurst DC (1999). False-positive rapid tests for malaria in patients with rheumatoid factor. Lancet, 353: 297.
Beal S, Racsa L, Alatoom A (2014). Implications of False Positive Serology of Toxoplasma gondii in a Pre-transplant Patient. Lab Med, 45: 56–58.
Abeijon C, Campos-Neto A (2013). Potential Non-invasive urine-Based antigen (Protein) detection assay to diagnose active visceral leishmaniasis. PLoS Negl Trop Dis, 7:e2161.
| Files | ||
| Issue | Vol 46 No 6 (2017) | |
| Section | Original Article(s) | |
| Keywords | ||
| False positivity KAtex Rheumatoid factor Autoimmune patients | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
